MedPath

Ibuprofen

Generic Name
Ibuprofen
Brand Names
Addaprin, Advil, Advil Cold and Sinus, Advil Congestion Relief, Advil PM, Advil Sinus Congestion and Pain, Alivio, Caldolor, Cedaprin, Children's Ibuprofen, Diphen, Duexis, Ibu, Ibutab, Junior Strength Motrin, Motrin, Motrin PM, Neoprofen, Nuprin, Pedea, Proprinal, Reprexain, Sudafed PE Head Congestion Plus Pain, Vicoprofen, Wal-profen Congestion Relief and Pain, Ibuprofen Gen.Orph
Drug Type
Small Molecule
Chemical Formula
C13H18O2
CAS Number
15687-27-1
Unique Ingredient Identifier
WK2XYI10QM

Overview

Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics. The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin. Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID. On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.

Background

Ibuprofen is a non-steroidal anti-inflammatory drug (NSAID) derived from propionic acid and it is considered the first of the propionics. The formula of ibuprofen is 2-(4-isobutylphenyl) propionic acid and its initial development was in 1960 while researching for a safer alternative for aspirin. Ibuprofen was finally patented in 1961 and this drug was first launched against rheumatoid arthritis in the UK in 1969 and USA in 1974. It was the first available over-the-counter NSAID. On the available products, ibuprofen is administered as a racemic mixture. Once administered, the R-enantiomer undergoes extensive interconversion to the S-enantiomer in vivo by the activity of the alpha-methylacyl-CoA racemase. In particular, it is generally proposed that the S-enantiomer is capable of eliciting stronger pharmacological activity than the R-enantiomer.

Indication

Ibuprofen is the most commonly used and prescribed NSAID. It is a very common over-the-counter medication widely used as an analgesic, anti-inflammatory and antipyretic. The use of ibuprofen and its enantiomer Dexibuprofen in a racemic mix is common for the management of mild to moderate pain related to dysmenorrhea, headache, migraine, postoperative dental pain, spondylitis, osteoarthritis, rheumatoid arthritis, and soft tissue disorder. Due to its activity against prostaglandin and thromboxane synthesis, ibuprofen has been attributed to alteration of platelet function and prolongation of gestation and labour. As ibuprofen is a widely used medication, the main therapeutic indications are:

Associated Conditions

  • Acute Pain
  • Ankylosing Spondylitis (AS)
  • Common Cold
  • Cystic Fibrosis (CF)
  • Fever
  • Gastric Ulcer
  • Gout
  • Headache
  • Insomnia
  • Juvenile Idiopathic Arthritis (JIA)
  • Menstrual Distress (Dysmenorrhea)
  • Migraine
  • Mild pain
  • Nasal Congestion
  • Osteoarthritis (OA)
  • Pain
  • Pain, Inflammatory
  • Patent Ductus Arteriosus (PDA)
  • Pericarditis
  • Primary Dysmenorrhoea
  • Rheumatoid Arthritis
  • Severe Pain
  • Sinus pressure
  • Mild to moderate pain
  • Minor aches and pains
  • Moderate Pain

FDA Approved Products

Hydrocodone Bitartrate and Ibuprofen
Manufacturer:Aurolife Pharma, LLC
Route:ORAL
Strength:200 mg in 1 1
Approved: 2021/03/24
NDC:13107-004
Ibuprofen and Famotidine
Manufacturer:Lupin Pharmaceuticals, Inc.
Route:ORAL
Strength:800 mg in 1 1
Approved: 2022/07/01
NDC:70748-312
Ibuprofen
Manufacturer:QPharma Inc
Route:ORAL
Strength:600 mg in 1 1
Approved: 2023/12/18
NDC:42708-097
Ibuprofen
Manufacturer:NuCare Pharmaceuticals,Inc.
Route:ORAL
Strength:800 mg in 1 1
Approved: 2023/05/25
NDC:68071-3415
Ibuprofen
Manufacturer:NuCare Pharmaceuticals,Inc.
Route:ORAL
Strength:400 mg in 1 1
Approved: 2023/09/20
NDC:68071-3507

Singapore Approved Products

No Singapore products found for this drug

Drug Development Updates

Stay informed with timely notifications on clinical trials and research advancements.

© Copyright 2025. All Rights Reserved by MedPath